Peripheral artery disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Peripheral artery disease (PAD) primarily results from atherosclerosis, where plaque buildup narrows and hardens the arteries, reducing blood flow to the limbs and leading to ischemia.

• Secondary mechanism: Endothelial dysfunction exacerbates PAD by impairing vasodilation and promoting inflammatory pathways, which further contribute to plaque formation and arterial stiffness.

• Key complication: Reduced blood flow can cause intermittent claudication and, in severe cases, critical limb ischemia, increasing the risk for ulcers, infections, and potentially leading to amputation if untreated.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Type 2 diabetes, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing leg pain while walking

• Key symptoms: Intermittent claudication, cold feet, numbness in toes, delayed wound healing on left foot

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, oxygen saturation 94% on room air

Section 1

As the healthcare team continues to monitor the 65-year-old male patient, new diagnostic results reveal further insights into his condition. An ankle-brachial index (ABI) test is conducted to assess the severity of his peripheral artery disease. The ABI results show a value of 0.65, indicating moderate PAD, which correlates with the patient's reported symptoms of intermittent claudication and numbness in his toes. In addition, a Doppler ultrasound of the lower extremities reveals significant stenosis in the superficial femoral artery, contributing to the impaired blood flow to the legs. These findings highlight the need for prompt intervention to prevent progression to critical limb ischemia.

Laboratory results also indicate poor glycemic control, with a hemoglobin A1c level of 8.5%, suggesting suboptimal management of his type 2 diabetes. Lipid panel results show elevated LDL cholesterol levels at 145 mg/dL, despite being on atorvastatin, indicating persistent hyperlipidemia. These results suggest a need to reassess the patient's medication regimen and lifestyle interventions to address these modifiable risk factors more effectively. The combination of diabetes, hypertension, and hyperlipidemia exacerbates endothelial dysfunction, further complicating his PAD.

The healthcare team decides to initiate a structured exercise program and optimize the patient's medication regimen. Cilostazol, a phosphodiesterase inhibitor, is added to improve walking distance by alleviating claudication symptoms. A referral to a dietitian is made to address dietary habits that may be contributing to poor glucose and lipid control. Clinically, the focus is on improving perfusion to the lower extremities and managing comorbid conditions to prevent further complications. The team anticipates that these interventions will stabilize the patient's condition, minimize symptoms, and enhance the patient's quality of life, while planning for follow-up assessments to evaluate the effectiveness of the therapeutic strategies.

Section 2

After four weeks of implementing the new structured exercise program and optimizing the medication regimen, the healthcare team conducts a follow-up assessment to evaluate the patient's response to the interventions. The patient reports a slight improvement in his walking distance, although he still experiences claudication after prolonged activity. Notably, there is decreased numbness in his toes, suggesting some improvement in peripheral perfusion. On examination, his vital signs reveal a blood pressure of 142/88 mmHg, indicating only a marginal improvement in hypertension management. The patient's weight remains unchanged, and he expresses difficulty adhering to the dietary modifications suggested by the dietitian.

Laboratory follow-up shows modest improvements; his hemoglobin A1c has decreased to 8.1%, reflecting better but still inadequate glycemic control. His LDL cholesterol level has reduced slightly to 138 mg/dL, despite the continued use of atorvastatin. These results suggest that while there is some progress, further refinement of the patient's treatment plan is necessary. The healthcare team recognizes the need to intensify lifestyle interventions, including more personalized dietary counseling and possibly adjusting his diabetes management plan, to achieve better control of these critical risk factors.

Given the persistent challenges, a new complication arises as the patient reports experiencing rest pain in his left foot, especially at night. This change raises concerns about progressing to critical limb ischemia. The healthcare team decides to perform an urgent reassessment, including a repeat Doppler ultrasound, to evaluate for any worsening stenosis or potential development of collateral circulation. The team understands the importance of timely intervention to prevent limb-threatening complications and contemplates the possibility of revascularization procedures if non-invasive measures prove insufficient. This scenario underscores the complexity of managing PAD and its comorbidities and the need for ongoing, dynamic clinical reasoning to adapt to the patient's evolving condition.

Section 3

The healthcare team promptly conducts an urgent reassessment to address the newly reported rest pain in the patient's left foot. During the initial assessment, the nurse notes that the patient appears visibly distressed about his worsening symptoms, which are significantly impacting his quality of sleep. On examination, the left foot is cooler to the touch compared to the right, with a capillary refill time extended to more than three seconds. The nurse also observes a faint dorsalis pedis pulse and absent posterior tibial pulse in the affected limb, suggesting worsening peripheral artery perfusion. The patient's vital signs reveal an increase in resting heart rate to 92 beats per minute, possibly reflecting sympathetic activation due to pain, and his blood pressure remains elevated at 148/90 mmHg, indicating suboptimal control of hypertension. These findings raise the clinical suspicion of progression toward critical limb ischemia, necessitating swift diagnostic clarification and intervention planning.

A repeat Doppler ultrasound is promptly ordered and reveals a significant decrease in the ankle-brachial index (ABI) to 0.4 on the left side, compared to 0.7 on the previous assessment. The ultrasound identifies a marked increase in stenosis within the superficial femoral artery, with diminished flow velocities suggesting severe compromise of blood flow. Additionally, there is evidence of compensatory collateral circulation development, although insufficient to relieve the ischemic symptoms fully. These findings confirm the suspicion of progressing vascular insufficiency and prompt the team to deliberate on the necessity of revascularization options, such as angioplasty or bypass surgery, as conservative measures appear inadequate.

The healthcare team discusses the situation with the patient, emphasizing the importance of addressing these new complications to prevent further deterioration and potential limb loss. The patient expresses concern and anxiety about the possibility of surgical intervention but acknowledges the need to prevent further complications. The team collaboratively decides to consult with a vascular surgeon to evaluate the suitability for revascularization and to explore any additional pharmacological adjustments, such as the introduction of cilostazol, which may improve symptoms and enhance quality of life. This moment of transition underscores the critical need for patient-centered communication and shared decision-making in managing complex, evolving conditions such as PAD.

Section 4

Following the consultation with the vascular surgeon, the patient is scheduled for an angioplasty procedure with potential stent placement, aimed at restoring adequate blood flow to the ischemic left lower extremity. The intervention is anticipated to relieve rest pain and prevent further deterioration, such as tissue necrosis. Before the procedure, the patient's pre-operative assessment reveals stable vital signs, with a heart rate of 88 beats per minute and a blood pressure of 144/88 mmHg, indicating slight improvement in blood pressure control following the adjustment of antihypertensive medications. However, the patient reports persistent left foot rest pain, now rated as 7 out of 10 on the pain scale, despite analgesic treatment.

Post-procedurally, the patient is closely monitored in the recovery unit. The immediate post-operative assessment shows encouraging results; the patient reports a reduction in pain, now rated at 3 out of 10, and there is a palpable dorsalis pedis pulse noted on the left foot, suggesting improved perfusion. The left foot is warmer to the touch, and capillary refill time decreases to 2 seconds, indicating better circulatory status. Continuous monitoring shows stable hemodynamics, with heart rate and blood pressure remaining within acceptable ranges. Despite the positive initial response, the healthcare team remains vigilant for potential complications such as re-occlusion, hematoma at the catheter site, or signs of infection.

In the days following the intervention, the patient is educated on lifestyle modifications to support vascular health, including smoking cessation, dietary adjustments, and a graded exercise program to enhance collateral circulation. Pharmacological management is optimized by introducing cilostazol to improve claudication symptoms. Regular follow-up appointments are scheduled to monitor the patient’s progress and ensure the long-term success of the intervention. The team emphasizes the importance of adherence to the treatment plan and regular monitoring of symptoms, paving the way for sustained improvement in quality of life and prevention of further complications.

Section 5

Several weeks after the angioplasty procedure, the patient arrives for a follow-up appointment, reporting intermittent pain and cramping in the left calf, particularly noticeable during periods of physical activity, such as walking. This new symptom, described as a 5 out of 10 on the pain scale, raises concerns about possible restenosis or insufficient collateral circulation development. Upon examination, the dorsalis pedis pulse remains palpable but slightly diminished compared to the initial post-operative assessment. The left foot is warm, and capillary refill remains at 2 seconds. Vital signs show a heart rate of 90 beats per minute and blood pressure of 146/92 mmHg, suggesting slight increases from previous measurements and necessitating a review of the patient's adherence to antihypertensive therapy.

To investigate further, the healthcare team orders a duplex ultrasound of the left lower extremity to assess blood flow and check for any signs of re-occlusion or new blockages. The results reveal mild restenosis at the site of the previous angioplasty, with a significant reduction in blood flow velocity in the affected segment. This finding indicates the potential need for additional intervention to maintain adequate perfusion and prevent further complications such as critical limb ischemia.

Given these developments, the care plan is adjusted to include a more aggressive pharmacological approach, possibly incorporating an antiplatelet agent in addition to cilostazol, to reduce the risk of thrombosis. The patient is counseled on increasing the intensity and duration of the graded exercise program to enhance muscle conditioning and improve circulation. The team underscores the importance of medication adherence and lifestyle modifications, emphasizing the need for regular monitoring and prompt reporting of any changes in symptoms, thereby fostering active participation in managing the condition and preventing progression.